CATABASIS PHARMACEUTICALS IN's ticker is and the CUSIP is 14875P206. A total of 28 filers reported holding CATABASIS PHARMACEUTICALS IN in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,000 | -100.0% | 233 | -100.0% | 0.00% | -100.0% |
| Q3 2020 | $18,866,000 | -3.7% | 3,047,800 | 0.0% | 0.04% | -8.3% |
| Q2 2020 | $19,597,000 | +54.9% | 3,047,800 | 0.0% | 0.05% | +29.7% |
| Q1 2020 | $12,648,000 | +0.8% | 3,047,800 | +43.6% | 0.04% | +32.1% |
| Q4 2019 | $12,546,000 | +6.1% | 2,122,800 | -3.0% | 0.03% | -3.4% |
| Q3 2019 | $11,823,000 | -33.1% | 2,189,400 | 0.0% | 0.03% | -32.6% |
| Q2 2019 | $17,668,000 | +1.9% | 2,189,400 | 0.0% | 0.04% | 0.0% |
| Q1 2019 | $17,340,000 | +280.3% | 2,189,400 | +109.8% | 0.04% | +258.3% |
| Q4 2018 | $4,560,000 | – | 1,043,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|